Bill Schief

Researcher at Scripps Research Institute and vice president of protein design at Moderna, presented strategies for an HIV vaccine inducing broadly neutralizing antibodies.

Hamburg acoge la Conferencia Europea de Terapia Génica de 2026 con énfasis en seguridad y avances en la vacuna contra el VIH